1. Lu L, Xiong W, Mu J, Zhang Q, Zhang H, Zou L, Li W, He L, Sander JW, Zhou D. The potential neurological effect of the COVID‐19 vaccines: a review. Acta Neurologica Scandinavica. 2021 Mar 29.
2. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Lu H, Stratton CW, Tang YW. J Med Virol. 2020;92:401–402.
3. Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID‐19 vaccines. Annals of neurology. 2021 May;89(5):856.
4. Allen A, Szabo L, Kaiser Health News . NIH “Very Concerned” about Serious Side Effect in Coronavirus Vaccine Trial [Internet]. Scientific American 2020.
5. Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV‐19 vaccine (AZD1222) against SARS‐CoV‐2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397:99–111.
6. Ledford H. US authorization of first COVID vaccine marks new phase in safety monitoring. Nature 2020;588:377–378.
7. Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021 Feb;13(2).
8. CDC . COVID‐19 Vaccination Considerations for Persons with Underlying Medica [Internet]. Centers for Disease Control and Prevention 2021.
9. Keddie S, Pakpoor J, Mousele C, et al. Epidemiological and cohort study finds no association between COVID‐19 and Guillain‐Barré syndrome.
10. European Medicines Agency . Vaxzevria (previously COVID‐19 Vaccine AstraZeneca)‐Safety updates 2021
11. Østergaard SD, Schmidt M, Horváth‐Puhó E, et al. Thromboembolism and the Oxford‐AstraZeneca COVID‐19 vaccine: side‐effect or coincidence? Lancet. 2021;397(10283):1441‐1443. 10.1016/s0140-6736(21)00762-5
12. Gee J. First Month of COVID‐19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
Facebook 
Masuk dengan Email
